Cargando…
Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema
Macular Edema (ME) is a common complication, leading to severe vision loss in patients with Non-Infectious Uveitis (NIU). The treatment of uveitic ME is still very challenging for many ophthalmologists. Various agents, such as corticosteroids, anti-vascular endothelial growth factors, and immune-mod...
Autores principales: | Karti, Omer, Saatci, Ali Osman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Hypothesis, Discovery & Innovation Ophthalmology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6229676/ https://www.ncbi.nlm.nih.gov/pubmed/30505868 |
Ejemplares similares
-
Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema
por: Karti, Omer, et al.
Publicado: (2021) -
The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
por: Al-Dhibi, Hassan, et al.
Publicado: (2014) -
Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
por: Saatci, Ali Osman, et al.
Publicado: (2013) -
Efficacy and safety of single-dose intravitreal dexamethasone implant in non-infectious uveitic macular edema: A systematic review and meta-analysis
por: Fan, Shipei, et al.
Publicado: (2023) -
Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
por: Weber, Lea F., et al.
Publicado: (2019)